Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

883
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
883
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

1.0K
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
1.0K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

115
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
115
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

154
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
154

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discrimination of crystal polymorphism in active pharmaceutical ingredients using time-domain <sup>1</sup>H NMR relaxation combined with multivariate statistical process control.

International journal of pharmaceutics·2026
Same author

Effect of Surfactants on Oral Delivery of Nanoemulsions Containing Fexofenadine, a Substrate for P-glycoprotein.

AAPS PharmSciTech·2025
Same author

HPV Education and Its Impact on Vaccination Willingness and Recommendation Intentions Among Unvaccinated Japanese University Students: A Cross-Sectional Study.

Journal of cancer education : the official journal of the American Association for Cancer Education·2025
Same author

Quantitative evaluation of crystallinity of active pharmaceutical ingredients in amorphous solid dispersion using T<sub>2</sub> relaxometry measured by time-domain NMR.

Journal of pharmaceutical sciences·2025
Same author

Solid Fat Content and Relaxation Time Measurement of Petrolatum Using Time-Domain NMR, and the Correlation with Viscosity and Crystallinity.

Chemical & pharmaceutical bulletin·2025
Same author

Foreword.

Chemical & pharmaceutical bulletin·2025

Related Experiment Video

Updated: Apr 27, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.9K

Latent structure modeling underlying theophylline tablet formulations using a Bayesian network based on a

Akihito Yasuda1, Yoshinori Onuki, Yasuko Obata

  • 1Formulation Development, CMC Research & Development Department, Discovery Research Labs., Nippon Shinyaku Co., Ltd. , Kisshoin, Minami-ku, Kyoto , Japan and.

Drug Development and Industrial Pharmacy
|July 5, 2014
PubMed
Summary

This study integrates advanced computational methods to model pharmaceutical quality by design. The developed approach accurately predicts tablet properties and clarifies relationships between formulation factors and drug responses.

Keywords:
Bayesian networkmultivariate analysisphysical characterizationself-organizing mapsimulationtablet formulation

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

2.1K
Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

2.9K

Related Experiment Videos

Last Updated: Apr 27, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.9K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

2.1K
Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

2.9K

Area of Science:

  • Pharmaceutical Science
  • Computational Chemistry
  • Data Science

Background:

  • Quality by Design (QbD) in pharmaceutical development necessitates a scientific basis and defined design space.
  • Understanding latent structures between formulation factors and drug product performance is crucial.

Purpose of the Study:

  • To integrate thin-plate spline (TPS) interpolation, Kohonen's self-organizing map (SOM), and Bayesian networks (BN) for visualizing causal and latent factors in pharmaceutical responses.
  • To quantitatively predict latent and response variables in theophylline tablet formulation.

Main Methods:

  • Utilized TPS for nonlinear prediction of latent variables (compressibility, cohesion, dispersibility) and response variables (tensile strength, disintegration time).
  • Employed SOM for clustering large datasets generated from pretableting blends and theophylline tablets.
  • Applied BN to SOM clustering results to visualize the latent structure between causal factors, latent variables, and responses.

Main Results:

  • Achieved high accuracy in predicting experimental values for latent and response variables.
  • Successfully classified tablet data into distinct clusters using SOM.
  • Demonstrated that BN analysis on SOM results effectively explains the underlying latent structure, confirming relationships between factors and responses.

Conclusions:

  • The integrated TPS, SOM, and BN approach provides a robust method for understanding complex relationships in pharmaceutical formulation.
  • This technique enhances the scientific rationale and design space establishment required by Quality by Design principles.
  • Offers a deeper insight into the connections between formulation variables and the final drug product's performance.